Keelung, Taiwan

Jenn-Kan Lu

This inventor holds 1 USPTO granted patent. Top assignee: Academia Sinica. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jenn-Kan Lu. Retrieved from https://idiyas.com/inventor/jenn-kan-lu-0j2rqnsb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Jenn-Kan Lu

Introduction

Jenn-Kan Lu is a prominent inventor based in Keelung, Taiwan. She has made significant strides in the field of antimicrobial research. Her work focuses on the development of novel peptides that can combat bacterial and fungal infections.

Latest Patents

Jenn-Kan Lu holds a patent for an antimicrobial peptide known as monodoncin. This peptide is isolated and purified through molecular cloning techniques in a heterologous expression system, such as yeast. Monodoncin exhibits a wide range of bacteriostatic and bactericidal effects on both Gram-negative and Gram-positive bacteria, as well as fungicidal activities. It can be used in combination with conventional antibiotics as 'cocktail therapy' to enhance their therapeutic effects.

Career Highlights

Jenn-Kan Lu is affiliated with Academia Sinica, a prestigious research institution in Taiwan. Her innovative work has contributed to advancements in antimicrobial therapies, showcasing her dedication to improving public health.

Collaborations

Some of her notable coworkers include Tze-Ting Chiou and Jen-Leih Wu. Their collaborative efforts have furthered research in the field of antimicrobial peptides.

Conclusion

Jenn-Kan Lu's contributions to antimicrobial research through her invention of monodoncin highlight her role as a leading inventor in the field. Her work not only advances scientific knowledge but also has the potential to improve therapeutic strategies against infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…